• Contact us
  • Investor Login
  • About
    • PAI at a glance
    • PAI today
    • Our heritage
    • Our sectors
    • Our funds and investors
    • Governance
    • Diversity
      & Inclusion
  • Investments
  • ESG
    • Our commitments
    • Our ESG reports
    • CSR in our portfolio companies
    • Thought leadership
    • SFDR disclosures
  • Team
  • Media
  • About
    • PAI at a glance
    • PAI today
    • Our heritage
    • Our sectors
    • Our funds and investors
    • Governance
    • Diversity
      & Inclusion
  • Investments
  • ESG
    • Our commitments
    • Our ESG reports
    • CSR in our portfolio companies
    • Thought leadership
    • SFDR disclosures
  • Team
  • Media
  • Contact us
  • Investor Login

Value creation and transformation of SGD Pharma

  • All
    media
  • PAI publications
  • Press releases
  • Videos
https://www.paipartners.com/language/en/mediaitem
  • Value creation and transformation of SGD Pharma

    5653
  • Value creation and transformation of SGD Pharma

    5653
  • Conversation with Christoph Gauer (CEO of ELITech Group) and Stefano Drago (Partner at PAI)

    5634
  • 25 Jul 2024

    PAI Partners to acquire majority stake in Nutripure

    Nutripure is a holistic wellness platform that allows consumers to take better care of their health. Initially designed for top-level athletes, Nutripure now provides almost 40 high-quality products for all consumers across Health & Metabolism, Sports & Endurance, Physical Recovery and Healthy Nutrition, serving over 200,000 clients.
    Read more 5628
  • 27 Jun 2024

    CVC agrees to acquire M Group Services from PAI Partners

    M Group Services has scaled significantly under PAI’s ownership: total revenues have increased from £1 billion in 2018 to over £2 billion, the order book has doubled in size, and the company has successfully delivered on a strategy to broaden its service offering and move up the value chain, acquiring 14 complementary businesses since 2018.
    Read more 5610
  • 2024 Annual General Meeting

    5600
  • 02 May 2024

    PAI Partners to acquire majority stake in Vamed’s European rehabilitation business

    Vamed’s rehabilitation business operates 67 clinics and care centres across Germany, Austria, Switzerland, the Czech Republic and the UK, serving more than 100,000 patients annually. Supported by around 10,000 highly-skilled staff, the unit provides a comprehensive range of inpatient and outpatient rehabilitation services, as well as specialist acute care.
    Read more 5596
  • 23 Apr 2024

    PAI Partners to acquire majority stake in Audiotonix

    Audiotonix is a global leader in the professional audio mixing console and ancillary products market. The group specialises in designing, engineering and manufacturing products that enable outstanding sound quality for a variety of formats, from live tours and concerts, theatre shows and major international live events to TV, film, sporting occasions and places of worship.
    Read more 5589
  • 18 Mar 2024

    PAI Partners to acquire majority stake in Beautynova

    Beautynova is a leading global professional haircare platform. The company is a leading developer of professional haircare products, with a premium portfolio of brands across hair treatment, colouring and styling and over 18,000 formulas.
    Read more 5567
  • 27 Dec 2023

    PAI Partners enters into agreement for the sale of ELITech Group to Bruker Corporation

    Under PAI ownership, ELITech Group has undergone transformative initiatives, including investment in R&D, the launch of next-generation molecular diagnostics systems and new strategic partnerships for product development. These efforts have helped strengthen ELITech’s competitive position and enhance its reputation as an industry innovator, resulting in substantial financial growth and profitability.
    Read more 5505
  • 2023: A year in review

    5503
12345‒19

Media enquiries

PAI Partners
Dania Saidam
+44 20 7297 4678
Greenbrook (UK)
Peter Hewer
Demi Kurban
+44 20 7952 2000
[email protected]
ICR (US)
Brian Ruby
Chris Gillick
+1 646 277 1298
[email protected]
H/Advisors Havas Paris (FR)
Sarah Duparc
+33 6 46 72 39 99
Estelle Bleuze
+33 6 73 97 94 17
[email protected]
Back to top
  • About
    • PAI at a glance
    • PAI today
    • Our heritage
    • Our sectors
    • Our funds and investors
    • Governance
    • Diversity
      & Inclusion
  • Investments
    • Business Services
    • Food & Consumer
    • Industrial Goods & Services
    • Healthcare
  • ESG
    • Our commitments
    • Our ESG reports
    • CSR in our portfolio companies
  • Team
    • Client & Capital Group
    • Communications Team
    • Compliance Team
    • Country Teams
    • ESG Team
    • Finance Team
    • HR Team
    • Investment Group
    • CCG
    • IT Team
    • Mid-Market Fund Team
    • PAI Performance Group
    • Sector Teams
  • Media
    • PAI publications
    • Press releases
    • Videos
© PAI 2025. | PAI Partners 2019 | PAI SAS: Registered in France No. 904 479 649, PAI SAS is a fund management company approved and regulated by the AMF in France (approval number GP-20240001). PAI Partners S.à r.l. : Registered in Luxembourg No. B136689. PAI Partners S.à r.l. is a fund management company approved and regulated by the CSSF in Luxembourg (approval number N. A00000625). PAI Partners (UK) Limited: Registered in the United Kingdom No 04015677. PAI Partners (UK) Limited is a financial advisory company approved and regulated by the FCA in the United Kingdom (approval number 984663). PAI and PAI Partners are registered trademarks.   
  • Investor Login
  • Contact us
  • Terms & Conditions
  • Legal disclaimer
  • Cookie Policy
  • Accessibility
  • Privacy notice
  • Whistleblowing Policy